Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 23.53% is 15% above its 5-year average of 20.51%, around the middle of its 5-year range (13.14%–47.15%).
As of the fiscal period ended Tuesday, June 30, 2026. 25.62% below its 12-month average of 31.64%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 23.53%.
DEBT TO ASSETS RATIO
23.53%
DEBT TO ASSETS RATIO AVG TTM
31.64%
DEBT TO ASSETS RATIO AVG 3Y
20.87%
DEBT TO ASSETS RATIO AVG 5Y
20.51%
DEBT TO ASSETS RATIO AVG 10Y
12.74%
DEBT TO ASSETS RATIO AVG 15Y
7.95%
DEBT TO ASSETS RATIO AVG 20Y
5.49%
CURRENT VS TTM AVG
-25.62%
CURRENT VS 3Y AVG
+12.76%
CURRENT VS 5Y AVG
+14.72%
CURRENT VS 10Y AVG
+84.66%
CURRENT VS 15Y AVG
+195.98%
CURRENT VS 20Y AVG
+329.02%
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 592 covered companies
CURRENT VS SECTOR MEDIAN
+23434.08%
vs the sector median at left
Geron Corporation
Market Cap
$769.83M
Debt to Assets Ratio
23.53%
TTM Avg
31.64%
3Y Avg
20.87%
5Y Avg
20.51%
Market Cap
$770.19M
Debt to Assets Ratio
0.24%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$768.50M
Debt to Assets Ratio
0.24%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$753.89M
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$750.11M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$791.01M
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$745.00M
Debt to Assets Ratio
0.06%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$742.59M
Debt to Assets Ratio
0.24%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Geron Corporation (GERN) | $769.83M | 23.53% | 31.64% | 20.87% | 20.51% |
| Mesa Laboratories, Inc. (MLAB)vs › | $770.19M | 0.24% | N/A | N/A | N/A |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $768.50M | 0.24% | N/A | N/A | N/A |
| Attovia Therapeutics, Inc. (ATTO)vs › | $753.89M | 0.03% | N/A | N/A | N/A |
| Design Therapeutics, Inc. (DSGN)vs › | $750.11M | 0.01% | N/A | N/A | N/A |
| Gyre Therapeutics, Inc. (GYRE)vs › | $791.01M | 0.02% | N/A | N/A | N/A |
| AdaptHealth Corp. (AHCO)vs › | $793.88M | 0.48% | N/A | N/A | N/A |
| Cytek Biosciences, Inc. (CTKB)vs › | $745.00M | 0.06% | N/A | N/A | N/A |
| Candel Therapeutics, Inc. (CADL)vs › | $742.59M | 0.24% | N/A | N/A | N/A |
| InMode Ltd. (INMD)vs › | $808.81M | 0.01% | N/A | N/A | N/A |
Debt/Assets
23.5%
Debt/Equity
0.56
Current Ratio
6.92
Interest Coverage
-1.6x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 23.53% |
| 2026-03-31 | 47.15% |
| 2025-12-31 | 44.09% |
| 2025-09-30 | 21.49% |
| 2025-06-30 | 21.95% |
| 2025-03-31 | 21.65% |
| 2024-12-31 | 20.50% |
| 2024-09-30 | 19.61% |
| 2024-06-30 | 19.37% |
| 2024-03-31 | 17.95% |
| 2023-12-31 | 21.80% |
| 2023-09-30 | 13.56% |
| 2023-06-30 | 13.47% |
| 2023-03-31 | 13.14% |
| 2022-12-31 | 29.26% |
| 2022-09-30 | 23.86% |
| 2022-06-30 | 23.22% |
| 2022-03-31 | 27.83% |
| 2021-12-31 | 24.33% |
| 2021-09-30 | 17.45% |
| 2021-06-30 | 15.80% |
| 2021-03-31 | 11.51% |
| 2020-12-31 | 10.98% |
| 2020-09-30 | 10.38% |
| 2020-06-30 | 2.13% |
| 2020-03-31 | 4.19% |
| 2019-12-31 | 1.54% |
| 2019-09-30 | 0.21% |
| 2019-06-30 | 0.24% |
| 2019-03-31 | 0.33% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 1.70% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | 0.38% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 0.00% |
| 2006-09-30 | 0.00% |
| 2006-06-30 | 0.00% |
| 2006-03-31 | 0.01% |
| 2005-12-31 | 0.03% |
| 2005-09-30 | 0.74% |
| 2005-06-30 | 1.31% |
| 2005-03-31 | 1.81% |
| 2004-12-31 | 2.46% |
| 2004-09-30 | 4.63% |
| 2004-06-30 | 4.33% |
| 2004-03-31 | 4.68% |
| 2003-12-31 | 5.24% |
| 2003-09-30 | 10.99% |
| 2003-06-30 | 11.66% |
| 2003-03-31 | 47.18% |
| 2002-12-31 | 42.89% |
| 2002-09-30 | 24.58% |
